PROCLEIX® Assays
PROCLEIX® ULTRIO Elite® Assay
The PROCLEIX ULTRIO Elite Assay is designed to offer increased blood safety through HIV-1, HIV-2, HCV and HBV detection. The test has been CE marked and is in development for use in other countries.
The PROCLEIX ULTRIO Elite Assay bears CE marking. The assay is in development and not available for commercial sale in the U.S. Performance characteristics of this product have not been evaluated by the FDA.
PROCLEIX ULTRIO Elite Assay outside US
PROCLEIX® ULTRIO Plus® Assay
The PROCLEIX ULTRIO Plus Assay is designed to detect HIV-1, HCV, and HBV in individual donors of blood, organs, cells, and tissues. The test currently has CE mark certification and is being developed for use in other countries.
Not available for use and sale in all countries. The PROCLEIX ULTRIO Plus Assay is CE Mark certified and approved for use in other markets. The assay is not currently available for commercial sale in the United States or China.
ULTRIO Plus Assay outside US and China
PROCLEIX® ULTRIO® Assay
The PROCLEIX ULTRIO Assay is designed to combine the early detection capabilities of NAT with single-tube TMA technology to deliver simultaneous results for HIV-1, HCV, and HBV.
Not available for use and sale in all countries
PROCLEIX® WNV Assay
The leading CE-mark certified and FDA-approved WNV assay with excellent performance, fast turnaround of less than 5 to 6 hours, and flexibility to run in single donor or pools of up to 16.
Not available for use and sale in all countries
